Pharmacogenomics for Primary Care: An Overview



Rollinson, Victoria, Turner, Richard ORCID: 0000-0002-7315-679X and Pirmohamed, Munir ORCID: 0000-0002-7534-7266
(2020) Pharmacogenomics for Primary Care: An Overview. GENES, 11 (11). E1337-.

[img] Text
Rollinson et al 2020 PGx Primary Care OpenAccess.pdf - Published version

Download (1MB) | Preview

Abstract

Most of the prescribing and dispensing of medicines happens in primary care. Pharmacogenomics (PGx) is the study and clinical application of the role of genetic variation on drug response. Mounting evidence suggests PGx can improve the safety and/or efficacy of several medications commonly prescribed in primary care. However, implementation of PGx has generally been limited to a relatively few academic hospital centres, with little adoption in primary care. Despite this, many primary healthcare providers are optimistic about the role of PGx in their future practice. The increasing prevalence of direct-to-consumer genetic testing and primary care PGx studies herald the plausible gradual introduction of PGx into primary care and highlight the changes needed for optimal translation. In this article, the potential utility of PGx in primary care will be explored and on-going barriers to implementation discussed. The evidence base of several drug-gene pairs relevant to primary care will be outlined with a focus on antidepressants, codeine and tramadol, statins, clopidogrel, warfarin, metoprolol and allopurinol. This review is intended to provide both a general introduction to PGx with a more in-depth overview of elements relevant to primary care.

Item Type: Article
Uncontrolled Keywords: pharmacogenomics, primary care, adverse drug reaction, implementation, antidepressants, warfarin, statins, clopidogrel, drug hypersensitivity
Depositing User: Symplectic Admin
Date Deposited: 30 Nov 2020 14:28
Last Modified: 18 Jan 2023 23:19
DOI: 10.3390/genes11111337
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3108729